chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Blood Clots both legs; had other vaccine same date at 2nd dose in the left arm; had other vaccine same date at 2nd dose in the left arm; This is a spontaneous report from a contactable Consumer (patient). A 69-year-old male patient received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9269) via an unspecified route of administration in the left arm on 15Apr2021 12:00 PM at single dose for COVID-19 immunization. Medical history was unknown. The patient had no known allergies. The patient had no covid prior vaccination, no covid tested post vaccination. The patient had no other vaccine in four weeks or other medications in two weeks. Concomitant medications were none. The patient had other vaccine same date at 2nd dose in the left arm. The patient experienced blood clots both legs on 15Apr2021 12:15 PM. The patient had extensive dvt IVC and both legs as treatment for event. Outcome of the event blood clots both legs was not recovered. AE resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization (duration: 5 days), Life threatening illness (immediate risk of death from the event).
This spontaneous report was received from a physician concerning to a patient of unknown age and gender. The physician reported that the patient received her first and second doses of GARDASIL (dose, route and lot not reported) on an unspecified dates in another unspecified facility and missed the third dose due to pregnancy. The physician stated that the patient was no longer pregnant and would like to receive her third dose. No adverse symptoms reported. No other co-suspects were reported. No concomitant medications were reported. The outcome of event was unknown. The event was not related to GARDASIL. Additional information has been requested.
This spontaneous report was received from a physician refers to a patient of unknown age who on an unknown date, was vaccinated with a dose MMR II (dose, route and lot number not reported) that was expired. No adverse effect was reported. Additional information has been requested.
Pt was breastfeeding and doing very well. On 7/20/12 received Hep B #2, Hib #1 and DTaP #1. Developed a small patch of eczema on face (very clear skin prior to that). On 8/16/12 received IPV #1 and PREVNAR #1. Since 3 days after has had very extensive eczema.
all muscles in body seized,  couldn't breathe,  body aches, fever, chills, headache
Robust local reaction, satellite lesions, pain at injection site beginning 3/12/03.  He was vaccinated 3/7/03
pain w/in 24 hrs of vax inc in intensity-reported to clinc 3-4 days later; pt exp cellulitis, arthritic changes (nothing acute); dx tendinitis; pain cont to intensify w/limited mobility of the arm interfering w/ability to sleep;
Approximately 20 minutes following my vaccine I developed a numbness/tingling in the left side of my face.  There was no visible drooping but the sensation was notable.  It is still present two days later and may be diminishing but I am uncertain.  I would classify the reaction as mild but was concerning to me initially.  No treatment was completed and I intend to just wait it out.
Fever, chill, heart pounding. On 4/17/2021 noticed slow to stop bleeding on a small cut on hand
Moderna COVID-19 Vaccine  The next day after the vaccine my right upper arm was sore. (I received the vaccine in my right shoulder.)  In the AM of the 6th day after the vaccine I woke with swollen, sore, tender lymph nodes of my right armpit. (Shot was received in right shoulder.) It is currently the evening of the 7th day after receiving the vaccine, and my right armpit lymph nodes are still sore, swollen, and tender.
Red, warm, swollen, tender on arm for 2 weeks. Went in on 1/14/21 for muscle weakness, numbness, and muscle spasms. Stuttering verbally started 1/27/21 and has not stopped. Muscle spasms, muscle weakness and fatigue have increased drastically from date of injection til now, tremors all over in the body,  when laying down to rest extremities at different times will involuntary jump. Had itching all over with no rash since 2nd week in February.
I became confused and could not find words. This was similar, but more severe to the reaction that I had from my first dose. 8 days after my first dose I went to urgent care, then to the ER where I had many tests including MRI and brain scan. Everything came back negative - no stroke, no seizure. The symptoms went away the next day. After consulting with my PCP he said it was OK to get the second dose. 8 days after my second dose (the reason for this submission) when similar but more severe symptoms presented, I was advised by my PCP to head directly to the ER. They performed MRI, brain scan, EEG and many other tests. Everything came negative, no stroke, no seizure. My PCP advised me 1) not to ever get a Shingrix shot again, that he was listing me as allergic to it and 2) to file this report with HHS. More detailed information is available from my medical record on file with my PCP. You have my permission to contact him and request a copy.
85 recruits were vaxed w/Td & yellow fever @ the same time; pts exp swelling & erythema surrounding vax site to a greater extent than was previously experienced;
Left thigh with 20cm by 14cm redness moderate swelling, hard to touch, tender in office today 11/8/2020.
The injection site became red, warm, and very itchy. It has been going on for two days now. I have taken some benadryl at times and it seems to help.
Fever, chills, body aches, dizziness, loss of appetite  I took Tylenol and ibuprofen alternately starting April 27 and  still taking them.
Still had hip pain; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness) and ARTHRALGIA (Still had hip pain) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Plaque psoriasis.    No Medical History information was reported.   On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose once a week. In 2021, the patient experienced FATIGUE (Tiredness). On an unknown date, the patient experienced ARTHRALGIA (Still had hip pain). In 2021, FATIGUE (Tiredness) had resolved. At the time of the report, ARTHRALGIA (Still had hip pain) had not resolved.            No Concomitant medications were reported. No treatment medications were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna
it got darker; it was a hard red mark; severe itching; could feel the shot; it hurt; 2 by 2 oval like rash on their shoulder; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 10-Feb-2021 and was forwarded to Moderna on 10-Feb-2021.    This spontaneous case was reported by a physician and describes the occurrence of ERYTHEMA (it was a hard red mark), PRURITUS (severe itching), VACCINATION SITE DISCOLOURATION (it got darker), VACCINATION SITE DISCOMFORT (could feel the shot) and PAIN (it hurt) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Dry eyes (Patient is currently taking medicine for dry eyes). Concomitant products included CICLOSPORIN (RESTASIS) for Dry eyes, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (TRELEGY), VITAMIN D3, MULTIVITAMIN [VITAMINS NOS], CALCIUM and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 26-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 28-Jan-2021, the patient experienced VACCINATION SITE DISCOMFORT (could feel the shot), PAIN (it hurt) and RASH (2 by 2 oval like rash on their shoulder). On 04-Feb-2021, the patient experienced PRURITUS (severe itching). On an unknown date, the patient experienced ERYTHEMA (it was a hard red mark) and VACCINATION SITE DISCOLOURATION (it got darker). On 28-Jan-2021, VACCINATION SITE DISCOMFORT (could feel the shot) had resolved. On 05-Feb-2021, PRURITUS (severe itching) had resolved. At the time of the report, ERYTHEMA (it was a hard red mark), VACCINATION SITE DISCOLOURATION (it got darker), PAIN (it hurt) and RASH (2 by 2 oval like rash on their shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient reported that the 2 by 2 oval like rash was very faint pink for the first few days, however it got darker and more red. On the morning of 04-Feb-2021, the patient experienced severe itching and applied unspecified antihistamine cream on it (details not provided) following which, severe itching resolved, however the red mark still persisted (faint pink in color). Patient also reported that hardness went away after the first week or so.
Lg induration on L ant. thigh with erythema 12.5cm (w)x8cm(L). Pt seen 9/19/02.
itching in the right arm; Shingrix and TDvax administered on the same day on left arm; blisters similar/like chickenpox on arm/located on the left arm; This case was reported by a nurse via call center representative and described the occurrence of injection site blisters in a 61-year-old female patient who received Herpes zoster (Shingrix) (batch number 3G33K, expiry date 10th July 2023) for prophylaxis.   Co-suspect products included PNEUMOCOCCAL VACCINE CONJ 20V (CRM197) (PREVNAR 20) for prophylaxis and DIPHTHERIA VACCINE TOXOID + TETANUS VACCINE TOXOID (TD VACCINE) for prophylaxis.   On 12th July 2022, the patient received the 1st dose of Shingrix, PREVNAR 20 and TD VACCINE. On 12th July 2022, unknown after receiving Shingrix, the patient experienced wrong technique in product usage process. On 14th July 2022, the patient experienced injection site blisters. On an unknown date, the patient experienced itchy upper limbs. On an unknown date, the outcome of the injection site blisters and itchy upper limbs were recovered/resolved and the outcome of the wrong technique in product usage process was unknown.   It was unknown if the reporter considered the injection site blisters and itchy upper limbs to be related to Shingrix.   Additional Information: GSK Receipt Date: 11-JAN-2023 Reporter's Comment: The reporter stated that the patient came into clinic and stated that after she received her Shingrix dose she had blisters similar to chickenpox that started 2 days after the dose. The blisters lasted 2 months and were now resolved. The blisters were located on left arm where the patient received Shingrix, as well as TDvax on the same day. The patient also received Prevnar 20 in the right arm at the same visit. The patient also had itching in the right arm. The patient showed it to her pharmacist, who agreed the blisters looked like chickenpox and not hives or a drug reaction rash. The patient did not seek medical care. At the time of reporting, the patient had not received a second dose. It was unknown if the reporter considered the injection site blisters and itchy upper limbs to be related to Td vaccine and Prevnar 20 vaccine. The reporter consented to follow up. Additional Supportive Information: The patient received Shingrix as well as TD vaccine on the same day in the left arm, which led to wrong technique in product usage process.
Pt. states that after receiving the 3rd dose of Moderna 01/15/2022, started experiencing symptom of a fever and "delays". 01/16/2022 symptoms of muscle aches with pain in the left side of the chest. Symptom of chest pain and "delays" still remain. No noted Primary visit/communications.
Itching and burning, immediately after administration.  Within the next few days, a warm, red, itchy lump appeared.
Large hive and itching on left thigh.  Very red, inflamed and itchy.
Heavy jaw, metallic taste in mouth, tingling to face and lips, fast heartbeat, pale feeling of passing out last about 15 mins or so given OJ Head between legs and then felt fine
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 28-DEC-2015 the patient was vaccinated with an improperly stored dose of ROTATEQ oral dose, 10-pack (lot # K010224, expiration date 13-MAY-2016). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 288 hours with the lowest recorded temperature of 1.11 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
On 9/21/06 developed maculo papular clusters confluent pink non tender but mildly purpuric rash consume anterior chest, and back. Rash intensity varied for first 2-3 days but steadily resolved so that by 9/27/06 the rash was minimal Not erythematous and barely palpable).
Developed joint pain in his left ankle, left knee and left wrist approximately 2 weeks following receipt of his 2nd anthrax vaccine. Significant left wrist pain (8/10) lasted about 5 days. Approximately 2 weeks following onset of left knee pain, he developed an effusion which was aspirated (x2) with negative cultures. Since then, he has experienced pain in multiple joints and tendons with no set pattern, but typically affecting only one joint at a time. Rheumatology and Infectious Disease consulted early in course with multiple labs completed and steroid taper, as well as NSAIDS prescribed. Currently taking TYLENOL BID for pain management. Also, since onset of joint pains, patient has experienced unexplained weight loss from baseline weight of 150 to 137.
pt recvd vax; devel lump at site, 7 1/2", hives for 24 hrs; tx w/ dph;
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concurrent conditions, medical history, or concomitant medications. In or about 2010, the patient's healthcare provider at an internal medicine office administered ZOSTAVAX to the patient to obtain permanent prevention and protection against shingles and zoster-related injuries/conditions (dose, route, and lot # not provided). On or about 21-NOV-2016, the patient was treated by a physician at the internal medicine office for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was not recovered. Causality assessment was related. Additional information has been requested.
Heart palpitations; Cheeks flushed; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via an unspecified route of administration in the right arm on 19Mar2021 at 11:15 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulphur products, penicillin and COVID-19. The patient did not receive any other medication within 2 weeks of vaccination. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 19Mar2021 at 12:30, the patient experienced heart palpitations within 30 minutes of taking the shot and also flushed cheeks. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the heart palpitations and flushed cheeks was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
ALLERGIC REACTION = HIVES ALL OVER BODY, SWOLLEN EYES, MOUTH & FACE, RUNNY NOSE, NO APPETITE.
A couple of days after the initial soreness (expected) went away, the shoulder joint is painful and has limited range of motion. Adduction and rotation cause pain. the elbow joint is stiff and the forearm and hand are tingly and slightly stiff.
Headache, Diarrhea, HA, Fatigue, Diarrhea Narrative:  Other Relevant History:
My armpit started to be swollen with dull ache and pain, about a week after the 1st shot. approximately 4 days later, it?s less swollen and not as achy, but symptoms are still present.
This case was reported by a healthcare professional and described the occurrence of diarrhea in a 53-year-old male subject who was vaccinated with HAVRIX (GlaxoSmithKline). Concurrent medical conditions included elevated cholesterol and thyroid problem. Previous and/or concurrent vaccination included ADACEL (non-gsk); Sanofi Pasteur given on 23 March 2009. Concurrent medications included Simvastatin, CYTOMEL, SYNTHROID and DIOVAN. On 23 March 2009 the subject received 1st dose of HAVRIX (unknown, left arm). On the morning of 24 March 2009, 1 day after vaccination with HAVRIX, the subject experienced diarrhea, nausea, vomiting and thought he was coming down with the flu. The same morning, he also experienced teeth hurting. At the time of reporting, teeth hurting was resolved; The diarrhea, nausea and vomiting improved; The outcome of possible flu was unspecified. The healthcare professional considered the diarrhea, nausea, vomiting and teeth hurting were possibly related to vaccination with HAVRIX. Follow-up information was received on 13 April 2009 from the reporting medical assistant. The events resolved on 26 March 2009. The medical assistant considered the events were possibly related to vaccination with HAVRIX. The medical assistant considered that the events could have been associated with medical history/concurrrent illness of possible coincidental concurrent viral illness.
feeling pretty sluggish; achy; has not been himself; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old male patient received bnt162b2 (BNT162B2), administration date 14Apr2021 (Batch/Lot number: unknown) at the age of 53 years as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "shingles" (unspecified if ongoing), notes: Stated that he did have shingles a couple of years ago and was pretty bad. Stated that he has not had the shingles vaccine. The patient's concomitant medications were not reported. The following information was reported: SLUGGISHNESS (non-serious), outcome "unknown", described as "feeling pretty sluggish"; PAIN (non-serious), outcome "unknown", described as "achy"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "has not been himself".  Additional information:  Caller stated that he had both shots of Pfizer and has been feeling pretty sluggish, achy and not himself for past couple of weeks. Stated that he had noticed there was question if he had the vaccine for shingles. Stated that he did have shingles a couple of years ago and was pretty bad. Stated that he has not had the shingles vaccine. Wanted to know if this had any impact on how bad the vaccine was. Stated that he had the second shot yesterday. Is for BioNTech Covid 19 vaccine.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Product supply issue; postural orthostatic tachycardia; positive HSV-1 IgG; This case was reported by a consumer via call center representative and described the occurrence of postural orthostatic tachycardia syndrome in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included cold sores. Concurrent medical conditions included postural orthostatic tachycardia syndrome.   On 5th December 2018, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. In May 2019, less than a year after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced postural orthostatic tachycardia syndrome and herpes simplex type i. On an unknown date, the patient experienced product supply issue. The patient was treated with valaciclovir hydrochloride (Valacyclovir). On an unknown date, the outcome of the postural orthostatic tachycardia syndrome, herpes simplex type i and product supply issue were unknown.   It was unknown if the reporter considered the postural orthostatic tachycardia syndrome and herpes simplex type i to be related to Shingrix.  Additional details were provided as follows: Prior to her first dose, on Thanksgiving, the patient experienced an episode of postural orthostatic tachycardia syndrome. She states this was evoked by a viral event. In May 2019, the patient had another event of this and was IgG positive for Herpes simplex virus 1. The patient noted she was not sure if this was something she had been aware of before, but noted she did have a history of cold sores. The patient was not sure if these events were related to the first injection, as she had had the events before. The patient was placed on valacyclovir in May 2019 for these events.  The patient had not received her 2nd dose of Shingrix yet due to unavailability. The patient called to see if she needed to stop the valacyclovir before getting her second dose.  The patient had been out of the country for 5 weeks, but had been contacted to say her second dose of Shingrix was now available at the pharmacy. The patient consented to follow up.
I had left side chest pain, I had shortness of breath. I went to the emergency room. Once I arrived at the emergency, I advised them I felt as if I were having a heart attack. They took me back to start running test. I had an EKG, ECG, CBC, bloodwork. All tests came back negative for heart attack. I was advised to see a cardiologist. On December 28th, I went to see my cardiologist. He is treating my high cholesterol, having me change my diet and as a result my cholesterol numbers are getting better.
30 minutes after injection,  bodily itching relieved after oral Zyrtec <24 hrs after injection,  fever > 101,  headache,  severe body aches,  nausea,  fatigue .  Symptoms lasted  >24 hrs
Chills and malaise starting at 2am 4/13/21 and lasting ~4 hours. Lethargy and malaise lingering for 4 days after that. Side effects vanished by sometime 4/16/21.